{
    "id": "64281a47690f196b5100004f",
    "question": "Is OXLUMO (lumasiran) used for the treatment of primary hyperoxaluria?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to identify the primary use of OXLUMO (lumasiran) and its classification as a medication. OXLUMO is a RNA interference therapy used for the treatment of primary hyperoxaluria type 1 (PH1), a rare genetic disorder that leads to excessive oxalate production in the body. PH1 can cause kidney stones, kidney failure, and other complications. The FDA approved OXLUMO in 2019 for the treatment of adults with PH1. Therefore, based on this information, we can conclude that OXLUMO is indeed used for the treatment of primary hyperoxaluria.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 4.127269983291626
}